1-3 of 3
Kent D. Stewart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C202: Discovery and initial characterization of the clinical compound ABT-348, a potent inhibitor of the VEGF, PDGF, and Aurora kinase families.

Michael L. Curtin, Robin Heyman, Robin R. Frey, Niru B. Soni, Patick A. Marcotte, Lori J. Pease, Keith B. Glaser, Terrance J. Magoc, Paul Tapang, Daniel H. Albert, Donald J. Osterling, Amanda M. Olson, Jennifer J. Bouska, Zhiwen Guan, Ruth L. Martin, Kent D. Stewart, Chris Tse, Steven K. Davidsen, Michael R. Michaelides
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C202.
https://doi.org/10.1158/1535-7163.TARG-11-C202
Published: 12 November 2011
View article titled, Abstract C202: Discovery and initial characterization of the clinical compound ABT-348, a potent inhibitor of the VEGF, PDGF, and Aurora kinase families.
Journal Articles

Abstract A245: Imidazo[2,1‐b]thiazole and imidazo[1,2‐a]pyridine amides as novel inhibitors of the insulin‐like growth factor (IGF1R) and members of the epidermal growth factor family of tyrosine kinases

Steve D. Fidanze, Scott A. Erickson, Robert D. Hubbard, Gary T. Wang, Robert A. Mantei, Nwe Y. BaMaung, Richard F. Clark, Bryan K. Sorensen, Peter Kovar, William Pappano, Qian Zhang, Julie L. Wilsbacher, Xiaoming Hu, Lora A. Tucker, Min Cheng, Kerren K. Swinger, Kent D. Stewart, Jieyi Wang, Randy L. Bell, Steven K. Davidsen, George S. Sheppard
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A245.
https://doi.org/10.1158/1535-7163.TARG-09-A245
Published: 10 December 2009
View article titled, Abstract A245: Imidazo[2,1‐b]thiazole and imidazo[1,2‐a]pyridine amides as novel inhibitors of the insulin‐like growth factor (IGF1R) and members of the epidermal growth factor family of tyrosine kinases
Journal Articles

Transforming Growth Factor β Mimetics: Discovery of 7-[4-(4-Cyanophenyl) phenoxy]-Heptanohydroxamic Acid, a Biaryl Hydroxamate Inhibitor of Histone Deacetylase

Keith B. Glaser, Junling Li, Mary E. Aakre, Douglas W. Morgan, George Sheppard, Kent D. Stewart, Jennifer Pollock, Paul Lee, Chad Z. O’Connor, Steven N. Anderson, Donna J. Mussatto, Craig W. Wegner, Harold L. Moses
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2002) 1 (10): 759–768.
Published: 01 August 2002
View article titled, Transforming Growth Factor β Mimetics: Discovery of 7-[4-(4-Cyanophenyl) phenoxy]-Heptanohydroxamic Acid, a Biaryl Hydroxamate Inhibitor of Histone Deacetylase
Open the PDF for Transforming Growth Factor β Mimetics: Discovery of 7-[4-(4-Cyanophenyl) phenoxy]-Heptanohydroxamic Acid, a Biaryl Hydroxamate Inhibitor of Histone Deacetylase in another window